Alaunos Therapeutics
TCRT • NASDAQ
Alaunos Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Holger Weis, with a market cap of $6.6M.
Market Cap$6.6M
Employees34.0
CEOHolger Weis
CountryUnited States of America
Healthcare
Biotechnology
Financials
Alaunos Therapeutics FAQ
Common questions about Alaunos Therapeutics
Alaunos Therapeutics has approximately 34 employees.